首页> 外文期刊>Cancer biology & therapy >Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV
【24h】

Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV

机译:miR-9-3p的升高抑制了通过下调FN1,ITGB1和ITGAV的鼻咽癌细胞的上皮 - 间充质转换

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs had been proved to be pivotal regulators in nasopharyngeal carcinoma (NPC) by regulating a large amount of genes' expression. In our research, we aim to explore the functions of miR-9-3p on the metastases of NPC and figure out the potential mechanisms. First, we revealed downregulation of miR-9-3p and upregulation of fibronectin 1 (FN1), 1 integrin (ITGB1) and 5 integrin (ITGAV) expression in NPC tissues and cells compared with the normal using RNA-seq analysis, RT-qPCR, western blot and immunohistochemistry. By transfection of miR-9-3p mimics in CNE-1, CNE-2 and HONE-1 cells, we confirmed tumor-suppressing roles of miR-9-3p via suppressing EMT process by MTT, wound scratch, transwell assay and western blot. After constructing luciferase reporting plasmids and transient transfection in HEK 293T cells, we proved that FN1, ITGB1 and ITGAV were all targets of miR-9-3p. Then we manipulated the expression of miR-9-3p, FN1, ITGB1 and ITGAV in HONE-1 cells, verifying the tumor-promoting effect of FN1, ITGB1 and ITGAV on cell proliferation and metastases via facilitating EMT process of cells. Additionally, these functions of FN1, ITGB1 and ITGAV could be efficiently abrogated by overexpression of miR-9-3p. Taken together, we demonstrated that elevation of miR-9-3p suppresses the proliferation and metastases of NPC via downregulating FN1, ITGB1, ITGAV and inhibiting the EMT process, which provided a series of therapeutic targets for the treatment of NPC.
机译:通过调节大量基因的表达,已经证明MicroRNA是鼻咽癌(NPC)中的枢轴调节剂。在我们的研究中,我们的目标是探讨MIR-9-3P对NPC转移并弄清楚潜在机制的功能。首先,我们透露了MiR-9-3P的下调和UIBRONECTIN 1(FN1)的上调,1-1种(ITGB1)和5整联蛋白(ITGAV)表达,与NPC组织和细胞中的表达与使用RNA-SEQ分析,RT-QPCR相比,蛋白质印迹和免疫组化。通过在CNE-1,CNE-2和HONE-1细胞中转染MiR-9-3P模拟,我们通过MTT,伤口划痕,Transwell测定和Western印迹通过抑制EMT过程确认了MiR-9-3P的肿瘤抑制作用。在构建荧光素酶报告质粒和HEK 293T细胞中的瞬时转染后,我们证明了FN1,ITGB1和ITGAV是MIR-9-3P的所有目标。然后,我们在磨河1个细胞中操纵miR-9-3p,fn1,Itgb1和Itgav的表达,验证Fn1,Itgb1和Itgav对细胞增殖和转移的肿瘤促进作用,通过促进细胞的过程。另外,通过MIR-9-3P的过表达可以有效地消除FN1,ITGB1和ITGAV的这些功能。我们占据了,我们证明MiR-9-3P的升高通过下调FN1,ITGB1,ITGAV和抑制EMT方法抑制NPC的增殖和转移,这提供了一系列治疗NPC的治疗靶标。

著录项

  • 来源
    《Cancer biology & therapy》 |2017年第6期|共11页
  • 作者单位

    Qingdao Univ Dept Reprod Med Affiliated Hosp Qingdao Shandong Peoples R China;

    Yuhuangding Hosp Yantai Dept Radiol Yantai Shandong Peoples R China;

    Cent Hosp Qingdao Dept Lab Med Qingdao Shandong Peoples R China;

    Peoples Hosp Zhangqiu Dept Radiol Jinan Shandong Peoples R China;

    Jining 1 Peoples Hosp Dept Oncol 6 Jiankang Rd Jining 272000 Shandong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    FN1; ITGB1; ITGAV; nasopharyngeal carcinoma; miR-9-3p;

    机译:FN1;ITGB1;ITGAV;鼻咽癌;MIR-9-3P;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号